Just wanted to post a slideshare presentation below that I was looking at from DCN Diagnostics.
"DCN Diagnostics is a provider of lateral flow assay development, training and commercialization services, along with related lateral flow products."
From the Anteo Diagnostics Quarterly report dated 30th October 2015 :
a) AMG™ Coupling Kit, 200 nm Magnetic Particles
Following the release of the 200nm kit, Anteo engaged US based DCN Diagnostics, a leading, globally recognised company for the commercialisation of high-performance, rapid assay systems, to evaluate the performance of the kit in a lateral flow assay.
Lateral flow assays are commonly used for applications such as pregnancy testing and are being developed for an increasingly wide range of other tests. The study compared the performance of the Mix&Go activated magnetic particles to covalently conjugated magnetic particles in a lateral flow assay that detects human Chorionic Gonadotropin (hCG). This hormone is used to detect early stage pregnancy and is a well- known and tested model system.
The conclusions of the study were:
1. The Anteo Mix&Go based hCG assay is 5 times more sensitive than the covalently conjugated magnetic particle based test using the same critical reagents.
2. The hCG assay using the Anteo Mix&Go particles used half the amount of antibody to achieve better sensitivity than the covalently conjugated particles.
3. The variability of the Anteo Mix&Go based hCG assay is lower than the covalently conjugated hCG assay. There is also less non-specific binding with the Mix&Go particles.
4. The Anteo Mix&Go particles come fully activated and are ready for the antibody conjugation. The covalent conjugation procedure requires steps to wash and activate the particles before the addition of the antibody. The Mix&Go procedure takes less time with fewer steps than the covalent conjugation procedure.
The outcomes of this evaluation are representative of the feedback we are receiving from customers, one of whom has entered into a supply agreement, to allow for the inclusion of Mix&Go into currently marketed tests, and several others are discussing terms.
That's about it for now - just wanted to put some of this together as I can see the lateral flow opportunities accelerating for Anteo over the coming years.
DISCLOSURE : THE AUTHOR HOLDS SHARES IN THIS COMPANY. THIS RESEARCH IS NOT A RECOMMENDATION TO BUY OR SELL SHARES IN THIS COMPANY. THE AUTHOR MAY AT ANY TIME BUY OR SELL SHARES WITHOUT NOTICE. PLEASE DO YOUR OWN RESEARCH